ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 212,91
0,31%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Somaxon Pharmaceuticals, Inc. (MM) (SOMX)

  7. Somaxon Pharmaceuticals, Inc. (MM) (SOMX) Actualités

SOMX

Somaxon (SOMX)

Somaxon Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SOMX
DateHeureSourceTitreSymboleSociété
06/03/201322h57Edgar (US Regulatory)(25-NSE)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
14/02/201321h57Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
07/02/201322h29Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
05/02/201323h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
05/02/201323h10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
05/02/201323h10Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
05/02/201322h30GlobeNewswire Inc.Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With ActavisNASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
04/02/201322h41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
04/02/201322h32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
28/01/201318h21ZacksPTX Reduces Sales Force, CFO Quits - Analyst BlogNASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
04/01/201319h15ZacksPernix Acquires Cypress and Hawthorn - Analyst BlogNASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
04/01/201301h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
04/01/201300h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
21/12/201222h41Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
21/12/201222h35Edgar (US Regulatory)Current report filing (8-K)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
21/12/201222h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
20/12/201222h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
20/12/201222h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
18/12/201218h19PR Newswire (US)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), C...NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
17/12/201222h35GlobeNewswire Inc.Somaxon Announces That Paladin Labs Has Received Approval of New Drug Submission for Silenor (R) in CanadaNASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
17/12/201218h59PR Newswire (US)Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals...NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
17/12/201217h55PR Newswire (US)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Intermec Inc. (IN), Somaxon Pharmaceuticals, Inc. (SOMX),...NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
14/12/201223h11Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
14/12/201203h30PR Newswire (US)Law Office of Brodsky & Smith, LLC Announces Investigation of Somaxon Pharmaceuticals, Inc.NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
12/12/201219h09Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
12/12/201216h59PR Newswire (US)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Plains Exploration & Production Company (PXP), Intermec I...NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
12/12/201215h41Business WireSomaxon Pharmaceuticals Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Pernix TherapeuticsNASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
11/12/201216h31Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Som...NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
11/12/201213h00GlobeNewswire Inc.Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
01/11/201211h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SOMXSomaxon Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:SOMX

Dernières Valeurs Consultées

EU
HO
Thales
EU
SGO
Cie de SaintGobain
EU
PX4
SBF 120
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
EU
AI
Air Liquide
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
EU
VIV
Vivendi
EU
PX1
CAC 40
EU
GLE
Societe Generale
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés